What are the Rome IV criteria for diagnosing irritable bowel syndrome?

Rome Criteria for IBS: Current Diagnostic Standards

The Rome IV criteria (not Rome V, which does not yet exist) are the current gold standard for diagnosing irritable bowel syndrome, requiring recurrent abdominal pain at least 1 day per week in the last 3 months (with symptom onset at least 6 months prior) associated with two or more of the following: improvement with defecation, change in stool frequency, or change in stool form. 1

Important Clarification

You asked about "Rome 5 criteria" - this does not exist. The most recent iteration is Rome IV, released in May 2016. The progression has been: Manning criteria → Rome I → Rome II → Rome III → Rome IV.

Rome IV Diagnostic Criteria

Core Requirements:

• Recurrent abdominal pain (note: "discomfort" was removed from Rome IV) at least 1 day per week in the past 3 months
• Symptom onset at least 6 months before diagnosis
• Pain must be associated with ≥2 of the following:
  • Related to defecation (can improve OR worsen with bowel movements)
  • Associated with a change in frequency of stool
  • Associated with a change in form (appearance) of stool

1

Key Changes from Rome III to Rome IV

Rome IV is more restrictive and identifies a more severe patient population:

• "Discomfort" eliminated - only abdominal pain counts (not vague discomfort, which had different meanings across languages) 2
• Pain frequency increased from "at least 3 days per month" to "at least 1 day per week" 3, 4, 2
• Pain relationship to defecation broadened - can now worsen with bowel movements, not just improve 2
• Result: Only 61-87% of Rome III IBS patients meet Rome IV criteria 3, 4, 5

Clinical Impact of Rome IV Criteria

Rome IV-positive patients demonstrate:

• More severe gastrointestinal symptoms 3, 4, 6
• Greater pain severity and bloating 3
• Higher rates of visceral hypersensitivity 3
• Poorer quality of life 3, 4, 5
• More psychological comorbidities 4
• Younger age and female predominance 4, 5

However, Rome IV criteria show:

• Lower diagnostic sensitivity (captures fewer patients) 5
• 19-30% lower prevalence rates compared to Rome III 6
• Excellent durability - only 1.1% missed organic disease over 4+ years follow-up 7

Practical Diagnostic Algorithm

Step 1: Confirm symptom pattern

• Abdominal pain ≥1 day/week for past 3 months
• Symptoms started ≥6 months ago
• Pain linked to defecation OR stool frequency OR stool form (need 2 of 3)

Step 2: Exclude alarm features

• Weight loss
• Rectal bleeding
• Nocturnal symptoms
• Anemia
• Age >45 at symptom onset (consider investigation)
• Family history of colon cancer

8

Step 3: Limited investigation (not exhaustive testing)

• Sigmoidoscopy if colonic symptoms present
• Consider: thyroid function, celiac serology, stool studies
• Colonoscopy/barium enema if age >45 or family history of colon cancer

8

Common Pitfalls

The Rome IV criteria may be too restrictive for real-world practice:

• 15-39% of Rome III IBS patients lose their diagnosis under Rome IV 3, 4
• Consider modification: Relaxing pain frequency back to 3 days/month improves diagnostic performance (sensitivity 90.2%, specificity 85.1%) while maintaining excellent positive likelihood ratio of 6.06 9
• Many patients reclassified as "unspecified bowel disorder" (24%) or "functional constipation" (17%) under Rome IV still have significant symptoms 5

Diagnosis is durable when made correctly:

• After proper Rome IV diagnosis with limited investigation, only 1.1% of patients had missed organic disease over 4+ years 7
• This validates the positive diagnostic approach rather than exhaustive exclusion

Supporting Features (Not Required but Helpful)

• Female sex, age <45, history >2 years 8
• Bloating, mucus passage, incomplete evacuation 1
• Non-GI symptoms: fatigue, fibromyalgia, urinary frequency 8
• Symptoms peak in 3rd-4th decades with 2:1 female predominance 1